{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T10:00:22Z","timestamp":1722938422041},"reference-count":0,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["VHRM"],"DOI":"10.2147\/vhrm.s55630","type":"journal-article","created":{"date-parts":[[2015,6,2]],"date-time":"2015-06-02T01:47:31Z","timestamp":1433209651000},"page":"283","source":"Crossref","is-referenced-by-count":3,"title":["Angiotensin receptor-neprilysin inhibitors: clinical potential in heart failure and beyond"],"prefix":"10.2147","author":[{"given":"Chim","family":"Lang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jagdeep","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2015,6]]},"container-title":["Vascular Health and Risk Management"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=25271","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,10,30]],"date-time":"2016-10-30T22:37:06Z","timestamp":1477867026000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.dovepress.com\/angiotensin-receptor-neprilysin-inhibitors-clinical-potential-in-heart-peer-reviewed-article-VHRM"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":0,"URL":"https:\/\/doi.org\/10.2147\/vhrm.s55630","relation":{},"ISSN":["1178-2048"],"issn-type":[{"value":"1178-2048","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6]]}}}